Simplify Logo

Full-Time

Executive Director

Head of Field Medical Affairs

Updated on 9/12/2024

Revolution Medicines

Revolution Medicines

201-500 employees

Develops targeted therapies for RAS cancers

Hardware
Biotechnology
Healthcare

Compensation Overview

$270k - $320kAnnually

+ Equity Awards + Benefits + Learning and Development Opportunities

Senior, Expert

San Carlos, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • Advanced, medical/scientific doctoral level degree required: MD, PharmD, PhD.
  • Demonstrated ability to create departmental capabilities, processes, and procedures to ensure alignment with desired outcomes.
  • 10+ years of experience in the Pharmaceutical or Biotech Industry with Medical Affairs.
  • 5+ years of experience in a leadership role managing Field Medical teams.
  • Global product launch experience.
  • Demonstrated expertise in oncology.
  • Demonstrated experience recruiting, hiring, and retaining Field Medical talent.
  • Demonstrated leadership skills (proactive, strategic, creates a highly accountable team culture, provides clear direction), project management and organizational skills, with the ability to evaluate competing priorities to arrive at an appropriate decision.
  • Collaborative, team-based approach; ability to network and partner with internal and external stakeholders, including medical thought-leaders and a wide range healthcare professionals.
  • Thorough understanding of applicable regulatory requirements for field-based personnel and PhRMA guidelines, including geographic regulatory related guidelines.
  • Demonstrated in-depth knowledge of Field Medical best practices.
  • Experience in recruiting, on-boarding, managing, coaching, and retaining talent.
  • Effective oral, written, and interpersonal skills required.
Responsibilities
  • Recruit, hire, onboard, and coach Field Medical team.
  • Lead development of the Field Medical deployment plan and standardization of Field Medical policies, processes, and operating procedures.
  • Provide critical input into building, optimizing and deploying systems including Customer Relationship Management, Medical insights, and territory planning tools.
  • Develop, deploy, and monitor key performance indicators; deliver and communicate reports to senior leadership monthly and as needed.
  • Provide leadership to the Field Medical team; develop and track team goals and ensure technical/ skills training.
  • Encourage and identify opportunities for professional development across the Field Medical team including developing and deploying career mapping across the Field Medical team.
  • Uphold and ensure compliance standards across the Field Medical team; support adherence to relevant regulatory requirements, required trainings and company Standard Operating Procedures.
  • Effectively demonstrate and communicate the value of Field Medical across the organization.
  • Create a robust Field Medical plan across US national, regional, and community healthcare practitioners, including academic institutions and community centers. Activate team to develop and execute individual territory plans annually and revisited quarterly or as needed.
  • Support development and execution of stakeholder engagement strategy to ensure timely and accurate scientific communication.
  • Drive scientific exchange and ensure the Field Medical team has the resources necessary to support robust communication, both proactive and reactive.
  • Drive insight generation to ensure actionable insights are generated, captured, and communicated across the organization.
  • Identify opportunities to support compliant and effective cross-functional collaboration across Clinical Development, Medical Affairs and Commercial teams, as needed and appropriate.
  • Provide strong input to strategic planning to ensure alignment with tactical execution.
  • Develop annual Field Medical tactical plan and aligned budget; monitor and manage the assigned budget and relationships with vendors to deliver projects in alignment with timelines and defined objectives.
  • Foster a culture of empowerment, collaboration, and a focus on patient impact.

Revolution Medicines develops targeted treatments for cancers caused by RAS gene mutations, which are common in difficult-to-treat cancers like pancreatic, colorectal, and lung cancers. Their main products are RASON Inhibitors, designed to inhibit the activity of RAS proteins that promote cancer growth. The company uses a Tri Complex Inhibitor platform to create these specialized therapies. Unlike many competitors, Revolution Medicines focuses specifically on RAS-driven cancers, allowing them to carve out a niche in the oncology market. Their goal is to transform cancer treatment by providing effective therapies for patients suffering from these challenging conditions.

Company Stage

IPO

Total Funding

$1.3B

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

12%

1 year growth

40%

2 year growth

111%
Simplify Jobs

Simplify's Take

What believers are saying

  • The acquisition of EQRx is expected to add over $1 billion in net cash, significantly bolstering Revolution Medicines' financial position.
  • Successful public offerings and underwriters' full exercise of options have brought substantial capital, indicating strong investor confidence.
  • The company's innovative RASON Inhibitors and Tri Complex Inhibitor platform have the potential to revolutionize treatment for RAS-driven cancers, offering significant clinical impact.

What critics are saying

  • The highly specialized focus on RAS-driven cancers may limit market size and revenue potential compared to broader oncology companies.
  • Integration challenges from the acquisition of EQRx could divert focus and resources, potentially impacting ongoing projects.

What makes Revolution Medicines unique

  • Revolution Medicines focuses exclusively on RAS-driven cancers, a niche but critical area in oncology, unlike broader-spectrum oncology companies.
  • Their Tri Complex Inhibitor platform allows for highly specialized treatments, setting them apart from competitors with more generalized approaches.
  • The company's revenue model, which includes licensing, co-development partnerships, and direct sales, provides multiple revenue streams, enhancing financial stability.